Literature DB >> 52675

The major histocompatibility complex of the guinea pig. I. Serologic and genetic studies.

A F Geczy, A L de Weck, B D Schwartz, E M Shevach.   

Abstract

Serologic and genetic studies of the antigens which comprise the guinea pig MHC have demonstrated three distinct but linked genetic regions. Antisera to the B region were raised by cross-immunization of random-bred animals; this region controls antigens B.1, B.2, B.3, and B.4 which behave as alleles at a single locus and which resemble the products of the murine D or K region genes in their tissue distribution and molecular characteristics. Cross-immunization of inbred strain 2 and strain 13 animals, both of which bear the B.1 antigen, leads to sera which identify antigens which resemble the products of the I region of the murine MHC. Specific absorption experiments have demonstrated four distinct I region antigens. In addition to the B and I regions, inbred strain 2, strain 13, and some outbred animals bear an antigen (S.1) which is the product of a third genetic region and which also resembles the murine D or K region gene products in molecular size. The results of these studies should facilitate the use of the guinea pig as an experimental model for studies of genetic control of the immune response and the function of the histocompatibility-linked Ir genes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 52675

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Identification of two Ia-like alloantigens on rabbit B lymphocytes.

Authors:  K L Knight; A L Leary; R G Tissot
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

2.  Zika Virus Infection in Syrian Golden Hamsters and Strain 13 Guinea Pigs.

Authors:  Lynn J Miller; Farooq Nasar; Christopher W Schellhase; Sarah L Norris; Adrienne E Kimmel; Stephanie M Valdez; Suzanne E Wollen-Roberts; Joshua D Shamblin; Thomas R Sprague; Luis A Lugo-Roman; Richard G Jarman; In-Kyu Yoon; Maria T Alera; Sina Bavari; M Louise M Pitt; Andrew D Haddow
Journal:  Am J Trop Med Hyg       Date:  2018-02-01       Impact factor: 2.345

3.  Antibodies to guinea-pig lymphokines. V. Suppression of normal lymphocyte transfer, immune lymphocyte transfer and direct reactions in the guinea-pig by anti-lymphokine globulin.

Authors:  F Hentges; C L Geczy; A F Geczy; A L De Weck
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

4.  Inhibition of T-antigen-binding cells by idiotypic antisera.

Authors:  C A Prange; J Fiedler; D E Nitecki; C J Bellone
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

5.  Differential characteristics of new inbred strains of guinea pigs.

Authors:  J Chiba; M Sugimoto
Journal:  Surv Immunol Res       Date:  1983

6.  Reproductive immunology in viviparous mammals: evolutionary paradox of interactions among immune mechanisms and autologous or allogeneic gametes and semiallogeneic foetuses.

Authors:  M Samardžija; M Lojkić; N Maćešić; H Valpotić; I Butković; J Šavorić; I Žura Žaja; D Leiner; D Đuričić; F Marković; P Kočila; Z Vidas; M Gerenčer; A Kaštelan; A Milovanović; M Lazarević; D Rukavina; I Valpotić
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

7.  Experimental allergic myositis: strain 13 guinea pig immunised with rabbit myosin B fraction.

Authors:  S Matsubara; M Takamori
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

8.  Langerhans cells present tick antigens to lymph node cells from tick-sensitized guinea-pigs.

Authors:  S Nithiuthai; J R Allen
Journal:  Immunology       Date:  1985-05       Impact factor: 7.397

Review 9.  The guinea pig as a model of infectious diseases.

Authors:  Danielle J Padilla-Carlin; David N McMurray; Anthony J Hickey
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

10.  Immune response to acute virus infection in the Syrian hamster. I. Studies on genetic restriction of cell-mediated cytotoxicity.

Authors:  M J Nelles; J W Streilein
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.